CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies, today announced that members of the management team will present at the following upcoming investor conferences:
• The Deutsche Bank 41st Annual Health Care Conference on Wednesday, May 4, 2016, at 2:10 p.m. ET at the InterContinental Hotel in Boston.
• The Bank of America Merrill Lynch 2016 Health Care Conference on Wednesday, May 11, 2016, at 2:20 p.m. PT at the Encore at Wynn Las Vegas in Las Vegas.
